epiglucan and Meningitis

epiglucan has been researched along with Meningitis* in 1 studies

Other Studies

1 other study(ies) available for epiglucan and Meningitis

Article	Year
Caution when using 1,3, β-D-glucan in the CSF as a biomarker of Candida albicans meningitis. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022, Volume: 122 Relying on a biomarker to diagnose or follow up the treatment of a Candida albicans meningitis would have an impact on patient management. The biomarker 1,3, β-D-glucan (BDG), developed for serum testing, shows inconsistent values when applied on cerebrospinal fluid (CSF), and its use with the current protocol on CSF samples warrants caution. Topics: beta-Glucans; Biomarkers; Candida albicans; Humans; Meningitis; Proteoglycans	2022

Article

Year

Caution when using 1,3, β-D-glucan in the CSF as a biomarker of Candida albicans meningitis.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022, Volume: 122

Relying on a biomarker to diagnose or follow up the treatment of a Candida albicans meningitis would have an impact on patient management. The biomarker 1,3, β-D-glucan (BDG), developed for serum testing, shows inconsistent values when applied on cerebrospinal fluid (CSF), and its use with the current protocol on CSF samples warrants caution.

Topics: beta-Glucans; Biomarkers; Candida albicans; Humans; Meningitis; Proteoglycans

2022